Table 2 Descriptive statistical results.
From: Breast cancer survival in a rural setting in the Busoga Region of Uganda
Variable | Number | Percentage |
|---|---|---|
Clinical presentation at enrollment | ||
Ulceration/infiltration | 104 | 40.6 |
Lymphadenopathy | 135 | 52.7 |
Both | 71 | 27.7 |
Any | 168 | 65.6 |
None | 88 | 34.4 |
Symptom duration before enrollment | ||
<1 year | 77 | 30.1 |
1–3 years | 108 | 42.2 |
>3 years | 57 | 22.3 |
Missing | 14 | 5.5 |
Referred to treatment after enrollment | ||
Yes | 77 | 30.1 |
No | 80 | 31.3 |
Referred before enrollment | 99 | 38.7 |
Time to treatment referral after enrollment (n = 77) | ||
<1 month | 53 | 68.8 |
>1 month | 22 | 28.6 |
Missing | 2 | 2.6 |
Received treatment outside RHHJ | ||
Yes (after enrollment) | 59 | 23.0 |
Yes (before enrollment) | 68 | 26.6 |
No | 119 | 46.5 |
Missing | 10 | 3.9 |
Time to treatment start after enrollment (n = 59) | ||
<1 month | 13 | 22.0 |
1–6 months | 36 | 61.0 |
>6 months | 7 | 11.9 |
Missing | 3 | 5.1 |
Time from diagnosis to enrollment | ||
Mean (SD) | 182.9 days (350.6) | |
